DOXAmdocs Limited

Technology

$58.85-28% 1Y

$58.85

$49.8752 weeks$84.19

Is the price fair?

Good

Undemanding: modest expectations priced in and cheap vs its sector.

2 good, 1 without data

What the price assumes~−6% a year

Priced for a decline (~−6% a year). The price demands less than its three-year revenue growth of 5% a year, expectations look modest.

Vs sector (EV/EBIT)8.6×

Sector median 30.5× across 203 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

All from derived, as of Sep 30, 2024.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)better than 75% of the market

FCF yieldbetter than 89% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What DOX's price assumes

Amdocs Limited trades at 13.8× earnings against 34.2× for the median Software - Infrastructure name, cheaper than its own group.

13.8

Trailing P/E · Software - Infrastructure median 34.2 · cheaper than the typical name in its group

Price / sales: 1.06
Price / sales · today's price, fiscal year to Sep 30, 2024
Free cash flow yield: 12%
Free cash flow yield · Software - Infrastructure median 5.3%
Growth the price implies: −5.8%
Growth the price implies · The price pays for −5.8% free cash flow growth a year for a decade; the business has delivered −4.7% a year over the last three.